0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Leukemias/Lymphomas
 41-60 of 68 Articles
Original Contribution |  FREE
Matthew C. Hull, MD; Christopher G. Morris, MS; Carl J. Pepine, MD; et al.
JAMA. 2003;290(21):2831-2837. doi:10.1001/jama.290.21.2831.

The World in Medicine | 
Joan Stephenson, PhD
JAMA. 2003;290(19):2535. doi:10.1001/jama.290.19.2535-a.

Original Contribution |  FREE
Nina S. Kadan-Lottick, MD, MSPH; Kirsten K. Ness, MPH; Smita Bhatia, MD, MPH; et al.
JAMA. 2003;290(15):2008-2014. doi:10.1001/jama.290.15.2008.

Original Contribution |  FREE
Ching-Hon Pui, MD; John T. Sandlund, MD; Deqing Pei, MS; et al.
JAMA. 2003;290(15):2001-2007. doi:10.1001/jama.290.15.2001.

Editorial | 
William L. Carroll, MD
JAMA. 2003;290(15):2061-2063. doi:10.1001/jama.290.15.2061.

Clinical Crossroads | 
Joseph H. Antin, MD
JAMA. 2003;290(8):1083-1090. doi:10.1001/jama.290.8.1083.
Includes: CME

Editorial | 
Joachim Yahalom, MD
JAMA. 2003;290(4):529-531. doi:10.1001/jama.290.4.529.

Medical News & Perspectives | 
JAMA. 2002;288(21):2676. doi:10.1001/jama.288.21.2676-JMN1204-1-0.

Original Contribution |  FREE
Scott C. Howard, MD, MS; Amar J. Gajjar, MD; Cheng Cheng, PhD; et al.
JAMA. 2002;288(16):2001-2007. doi:10.1001/jama.288.16.2001.

Original Contribution |  FREE
Nina S. Kadan-Lottick, MD, MSPH; Leslie L. Robison, PhD; James G. Gurney, PhD; et al.
JAMA. 2002;287(14):1832-1839. doi:10.1001/jama.287.14.1832.

From the Food and Drug Administration | 
Lester M. Crawford, Jr, DVM, PhD
JAMA. 2002;287(13):1640. doi:10.1001/jama.287.13.1640.

Original Contribution |  FREE
Carlo Catassi, MD; Elisabetta Fabiani, MD; Giovanni Corrao, PhD; et al.
JAMA. 2002;287(11):1413-1419. doi:10.1001/jama.287.11.1413.

The World in Medicine | 
Joan Stephenson, PhD
JAMA. 2002;287(10):1255. doi:10.1001/jama.287.10.1255.

From the Food and Drug Administration | 
Bernard A. Schwetz, DVM, PhD
JAMA. 2002;287(9):1103. doi:10.1001/jama.287.9.1103-JFD20003-2-1.

Special Communication | 
Yuri Pekarsky, PhD; Cora Hallas, PhD; Carlo M. Croce, MD
JAMA. 2001;286(18):2308-2314. doi:10.1001/jama.286.18.2308.

Health Agencies Update | 
Brian Vastag
JAMA. 2001;286(11):1306. doi:10.1001/jama.286.11.1306.

JAMA Patient Page |  FREE
JAMA. 2001;286(8):994. doi:10.1001/jama.286.8.994.

From the Food and Drug Administration | 
Bernard A. Schwetz, DVM, PhD
JAMA. 2001;286(1):35. doi:10.1001/jama.286.1.35.

JAMA Patient Page |  FREE
JAMA. 2001;285(14):1920. doi:10.1001/jama.285.14.1920.

Medical News & Perspectives | 
Joan Stephenson, PhD
JAMA. 2001;285(2):153-155. doi:10.1001/jama.285.2.153.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Dermatology
Observation  | 
Cutaneous Hemophagocytosis After Alemtuzumab Injection in a Patient With Sézary Syndrome
Sarah I. Jawed, BA; Klaus Busam, MD; Xuan Wang, MD, PhD; et al.
JAMA Dermatology
Original Investigation  | 
Outcomes After Diagnosis of Mycosis Fungoides and Sézary Syndrome Before 30 Years of Age:  A Population-Based Study
Weiyun Z. Ai, MD, PhD; Theresa H. Keegan, PhD, MS; David J. Press, MPhil; et al.
JAMA Dermatology
Research Letter  | 
Alemtuzumab Therapy for Leukemic Cutaneous T-Cell Lymphoma:  Diffuse Erythema as a Positive Predictor of Complete Remission
Rei Watanabe, MD, PhD; Jessica E. Teague, PhD; David C. Fisher, MD; et al.
JAMA Ophthalmology
Original Investigation  | 
Ocular Adnexal Follicular Lymphoma:  A Multicenter International Study
Peter K. Rasmussen, MD, PhD; Sarah E. Coupland, PhD, MBBS ; Paul T. Finger, MD, DMSc; et al.